50
Participants
Start Date
September 1, 2025
Primary Completion Date
March 1, 2026
Study Completion Date
April 1, 2026
Tirzepatide
GLP-1 based treatment for obesity
Lifestyle toolkit
2 ABBOTT protein shakes daily and resistance-based exercise x 3 days per week.
Robert L. Dubin, MD, Baton Rouge
Pennington Biomedical Research Center
OTHER